rxstat › Shortages › Bendamustine
Bendamustine shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Bendamustine products are in shortage in Canada (2 of 8 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jan 1, 2025.
In shortage since
Jul 19, 2022
Est. full return
Jan 1, 2025
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageBENDAMUSTINE HYDROCHLORIDE FOR INJECTION
25MG · POWDER FOR SOLUTION · JAMP PHARMA CORPORATION
DIN 02509164 · since Jul 19, 2022, est. end Jan 1, 2025 · Disruption of the manufacture of the drug.
Active shortageBENDAMUSTINE HYDROCHLORIDE FOR INJECTION
100MG · POWDER FOR SOLUTION · JAMP PHARMA CORPORATION
DIN 02509172 · since Jul 19, 2022, est. end Dec 31, 2023 · Disruption of the manufacture of the drug.
ResolvedBENDAMUSTINE HYDROCHLORIDE FOR INJECTION
100MG · POWDER FOR SOLUTION · ACCORD HEALTHCARE INC
DIN 02496860 · ended Jan 9, 2026 · Requirements related to complying with good manufacturing practices.
ResolvedBENDAMUSTINE HYDROCHLORIDE FOR INJECTION
25MG · POWDER FOR SOLUTION · ACCORD HEALTHCARE INC
DIN 02496852 · ended Jan 9, 2026 · Requirements related to complying with good manufacturing practices.
ResolvedTREANDA
100MG · POWDER FOR SOLUTION · TEVA CANADA LIMITED
DIN 02392569 · ended May 1, 2025 · Disruption of the manufacture of the drug.
ResolvedBENDAMUSTINE HYDROCHLORIDE FOR INJECTION
100MG · POWDER FOR SOLUTION · AURO PHARMA INC
DIN 02509261 · ended Feb 18, 2025 · Other (Please describe in comments)
ResolvedBENDAMUSTINE HYDROCHLORIDE FOR INJECTION
25MG · POWDER FOR SOLUTION · AURO PHARMA INC
DIN 02509253 · ended Feb 18, 2025 · Other (Please describe in comments)
ResolvedTREANDA
25MG · POWDER FOR SOLUTION · TEVA CANADA LIMITED
DIN 02392550 · ended Jan 16, 2025 · Disruption of the manufacture of the drug.
ResolvedTREANDA
100MG · POWDER FOR SOLUTION · TEVA CANADA LIMITED
DIN 02392569 · ended Feb 10, 2021 · Disruption of the manufacture of the drug.
What's happening
Bendamustine is currently affected by 2 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Bendamustine is classified under “ALKYLATINGAGENTS” (ATC L01AA).
Recent changes
Common questions
When will Bendamustine be back in stock in Canada?
The latest manufacturer estimate is Jan 1, 2025. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Bendamustine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
All alkylatingagents shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.